Kidswell Bio Corporation [4584.T]
TOKYO, May 14 (Pulse News Wire) – Kidswell Bio Corporation (4584.T) reported consolidated results for fiscal year 2026 ending March. Revenue was ¥6.6 billion (+29.7% YoY).
Operating profit was ¥138 million. net profit was ¥413 million.
Total assets stood at ¥6.1 billion with an equity ratio of 26.4%. The full-year forecast for the current fiscal year is revenue of ¥5.0 billion.
Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥6,589M | +29.7% |
| Operating profit | ¥-138M | -374.0% |
| Net profit | n/a | n/a |
Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.